Keisuke Watanabe
Tokyo, 2778577, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.
Journal: Science translational medicine
Published: April 15, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia.
Journal: Blood advances
Published: September 29, 2025
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia.
Journal: Blood advances
Published: September 29, 2025
Clinical, immunological, and genomic findings of atezolizumab in advanced alveolar soft part sarcoma: A phase II trial (ALBERT trial/NCCH1907).
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 31, 2025
CAR T cells targeting CCR4 selectively deplete human Tregs ex vivo and in vivo.
Journal: Blood advances
Published: June 24, 2025
Ponatinib inhibits LCK and PI3K signaling and promotes CD8+ T stem cell memory cell development.
Journal: Nature communications
Published: March 24, 2025
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 15, 2023
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma.
Journal: Blood advances
Published: June 13, 2022
An NK-like CAR T cell transition in CAR T cell dysfunction.
Journal: Cell
Published: November 04, 2020
Artificial T Cell Adaptor Molecule-Transduced TCR-T Cells Demonstrated Improved Proliferation Only When Transduced in a Higher Intensity.
Journal: Molecular therapy oncolytics
Published: June 19, 2020
Last Updated: 09/26/2026